24 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Cmpds
Data
Article Title
Organization
24
Design of selective Cathepsin inhibitors.

AstraZeneca
34
Evaluation of synthetic acridones and 4-quinolinones as potent inhibitors of cathepsins L and V.

Universidade Federal De S£O Carlos
5
Grassystatins A-C from marine cyanobacteria, potent cathepsin E inhibitors that reduce antigen presentation.

University of Florida
16
The discovery of odanacatib (MK-0822), a selective inhibitor of cathepsin K.

Merck Frosst Centre For Therapeutic Research
11
Acridone alkaloids as potent inhibitors of cathepsin V.

Universidade Federal De S£O Carlos
12
1H-imidazo[4,5-c]pyridine-4-carbonitrile as cathepsin S inhibitors: separation of desired cellular activity from undesired tissue accumulation through optimization of basic nitrogen pka.

Merck Research Laboratories
24
Identification of potent and reversible cruzipain inhibitors for the treatment of Chagas disease.

Merck Research Laboratories
24
Trifluoromethylphenyl as P2 for ketoamide-based cathepsin S inhibitors.

Merck Research Laboratories
3
MK-7009, a potent and selective inhibitor of hepatitis C virus NS3/4A protease.

Merck Research Laboratories
78
Peptidomimetic Analogues Act as Effective Inhibitors against SARS-CoV-2 by Blocking the Function of Cathepsin L.

Nankai University
18
Discovery of CMX990: A Potent SARS-CoV-2 3CL Protease Inhibitor Bearing a Novel Warhead.

Calibr At Scripps Research Institute
10
Bicyclic carbamates as inhibitors of papain-like cathepsin proteases.

The Genomics Institute of The Novartis Research Foundation
5
Potent Anti-SARS-CoV-2 Activity by the Natural Product Gallinamide A and Analogues via Inhibition of Cathepsin L.

The University of Sydney
18
P2-P3 conformationally constrained ketoamide-based inhibitors of cathepsin K.

Glaxosmithkline
10
A structural screening approach to ketoamide-based inhibitors of cathepsin K.

Glaxosmithkline
14
Natural dimers of coumarin, chalcones, and resveratrol and the link between structure and pharmacology.

Nagasaki International University
1
The marine cyanobacterial metabolite gallinamide A is a potent and selective inhibitor of human cathepsin L.

University of California
26
Repurposing a Library of Human Cathepsin L Ligands: Identification of Macrocyclic Lactams as Potent Rhodesain and Trypanosoma brucei Inhibitors.

Eth Zurich
182
Pyranopyrazole and pyrazolopyridine immunomodulators for treatment of autoimmune diseases

Rockefeller University
203
Substituted carbonucleoside derivatives useful as anticancer agents

Pfizer
12
Use of small molecule inhibitors targeting EYA tyrosine phosphatase

Cincinnati Childrens Hospital Medical Center
231
Substituted tricyclic compounds as FGFR inhibitors

Incyte